Daily Recap
Former U.S. Sen. Cory Gardner told a panel on the first day of the Benzinga Cannabis Capital Conference in Florida that several ranking Congress members are intending to attach the SAFER Banking Act to the must-pass FAA reauthorization.
"It might not be pretty but it will get the job done," the Colorado Republican told the Benzinga conference.
During the same panel, former U.S. Rep. Ed Perlmutter hinted at imminent regulatory changes that could benefit the cannabis industry, stating: “The DEA will help with 280E and so forth, and hopefully we’ll see a decision this week, or soon.”
Reefer Gladness
A new report published by the the American Medical Association finds that neither adult-use marijuana legalization nor the opening of retail stores in U.S. states led to increases in youth cannabis use.
Rather, the reforms were generally associated with more young people reporting not using marijuana, along with increases in those who say they don’t use alcohol or vape products either.
Show Pony
Total marijuana sales in Missouri reached just under $125M for the month of March, yet another new record for the state, which just launched recreational canna sales in February last year.
Dakota Fawning
North Dakota activists filed an initiative to put marijuana legalization on the state’s 2024 ballot, pitching their reform proposal as a “conservative” alternative to the cannabis laws in surrounding states such as Minnesota and Montana.
Stocks & Stuff
It was a whippy trip for cannabis stocks as the industry weaved its way through Day 2 of the Benzinga Cannabis Conference. U.S. cannabis ETF MSOS rallied more than 6% on unsubstantiated chatter and innuendo that federal reform is imminent
Below, we’ll recap the sights, sounds, thoughts, insights and observations from the Benzinga Cannabis Capital Conference from sunny Hollywood, Florida, and touch on the news and views that are shaping stock prices.
All that and more, just scroll down.
SPY 0.00%↑ QQQ 0.00%↑ IWM 0.00%↑ MSOS 0.00%↑ PT Notional: $175M/$115M
Top Stories
Keep reading with a 7-day free trial
Subscribe to Cannabis Confidential to keep reading this post and get 7 days of free access to the full post archives.